| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |